ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 100 filers reported holding ALBIREO PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $193,000 | -15.7% | 6,197 | -5.0% | 0.08% | -9.6% |
| Q2 2021 | $229,000 | -11.2% | 6,523 | -11.0% | 0.09% | -13.8% |
| Q1 2021 | $258,000 | -4.4% | 7,326 | +1.9% | 0.11% | -2.7% |
| Q4 2020 | $270,000 | -42.4% | 7,192 | -49.5% | 0.11% | +133.3% |
| Q3 2018 | $469,000 | -46.5% | 14,240 | -42.3% | 0.05% | -93.8% |
| Q2 2018 | $876,000 | – | 24,688 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |